BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates

  GH Research PLC reported financial results for the first quarter ended March 31, 2022 and gave updates on its business.

  May 18, 2022

   · 

  7 min read
• Business

  IONETIX AND ATONCO SIGN A PARTNERSHIP AGREEMENT TO FIGHT BLADDER CANCER

  The companies Atonco (Nantes-Saint Herblain, France ) and IONETIX Corporation ( Lansing, MI ) have signed a partnership agreement to ensure the radioisotope production and supply of the radiopharmaceutical necessary for the success of Atonco’s clinical studies and commercialization in the United States.

  May 18, 2022

   · 

  3 min read
• Genetown

  Ginkgo Bioworks and First Serv Announce Plans to Develop and Implement Innovative Global Biosecurity Capabilities in Qatar

  Ginkgo Bioworks, the leading horizontal platform for cell programming, and First Serv, a Qatari investment holding company, announced that they have entered into a non-binding Memorandum of Understanding to develop and implement new biosecurity capabilities in Qatar.

  May 18, 2022

   · 

  6 min read
• Business

  IceCure Medical Reports First Quarter 2022 Financial Results and Operational Highlights

  IceCure Medical Reports First Quarter 2022 Financial Results and Operational Highlights.

  May 18, 2022

   · 

  11 min read
• Drug Development

  Axsome Therapeutics Announces Publication of Pivotal ASCEND Phase 2 Trial of AXS-05 in Major Depressive Disorder in The American Journal of Psychiatry

  Axsome Therapeutics, Inc. today announced the publication of the results from the pivotal ASCEND Phase 2 clinical trial of AXS-05 (dextromethorphan-bupropion) in major depressive disorder (MDD).

  May 18, 2022

   · 

  8 min read
• Drug Development

  EpiEndo: Successful Completion of Phase I Study for Lead Asset EP395

  bFirst non-antibiotic macrolide to go into clinical development – targeting COPD Safety, tolerability and pharmacokinetic endpoints met Phase II planning underway

  May 18, 2022

   · 

  3 min read
• Drug Development

  Bicara Therapeutics to Present Clinical Data from Lead Bifunctional Antibody Program, BCA101, at ASCO 2022 Annual Meeting

  Bicara Therapeutics today announced that it will present updated data from the dose escalation phase of its ongoing Phase 1 trial of BCA101.

  May 18, 2022

   · 

  2 min read
• Genetown

  METiS Joins the Roche Accelerator

  METiS announced officially joining the Roche Accelerator with the goal to tap into Roche’s global scientific expertise, laboratory facilities and foster collaboration discussions on formulation development and optimization with Roche Innovation Center Shanghai.

  May 18, 2022

   · 

  2 min read
• Drug Development

  Precision BioSciences Announces Publication in Molecular Therapy of ARCUS® In Vivo Gene Editing as a Promising Therapeutic Approach to Cure Chronic Hepatitis B Infection

  Precision BioSciences Announces Publication in Molecular Therapy of ARCUS® In Vivo Gene Editing as a Promising Therapeutic Approach to Cure Chronic Hepatitis B Infection.

  May 18, 2022

   · 

  8 min read
• Biotech Beach

  Otonomy to Participate in the H.C. Wainwright Global Investment Conference

  Otonomy, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, announced its participation in the H.C. Wainwright Global Investment Conference.

  May 18, 2022

   · 

  1 min read